Dutch media, including NRC, de Volkskrant, AD, and De Telegraaf, have been fined tens of thousands of euros for their reporting on weight loss medications such as Ozempic and Wegovy, as the Health and Youth Care Inspectorate (IGJ) considers these articles to be public advertising, and the editors-in-chief fear that this puts press freedom under pressure. (translated)



